Product
ChAdOx1-VZV
1 clinical trial
1 indication
Indication
Herpes ZosterClinical trial
A Phase I, Randomized, Observer Blind Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Zoster Vaccine (Adenovirus Vector) in Healthy Adults Aged 50-65 YearsStatus: Recruiting, Estimated PCD: 2024-09-01